Literature DB >> 10843802

Construction of a 350-kb sequence-ready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546: mapping of 11 genes and 3 tumor-associated translocation breakpoints.

M van Asseldonk1, M Schepens, D de Bruijn, B Janssen, G Merkx, A Geurts van Kessel.   

Abstract

Previously, we located three novel human tumor-associated translocation breakpoints in the chromosome 11q13 region between the markers D11S4933 and D11S546. To facilitate the molecular analysis of these breakpoints, we have constructed a continuous sequence-ready cosmid and PAC contig of approximately 350 kb, including the markers D11S4933 and D11S546. In addition, a detailed transcript map was generated. This resulted in the precise positioning of 11 genes and ESTs within the contig, including 4 genes already known to map in the 11q13 region. Three other genes that we positioned within the contig showed homologies to unmapped genes from human and/or other species. Three ESTs were novel. Partial cosmid sequencing resulted in the establishment of the direction of transcription of several of the reported genes. This contig will be instrumental for the detailed characterization of the tumor-associated chromosomal breakpoints and the identification of other 11q13-associated disease genes. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843802     DOI: 10.1006/geno.2000.6194

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  11 in total

1.  Control of RNA processing by a large non-coding RNA over-expressed in carcinomas.

Authors:  Rui Lin; Manami Roychowdhury-Saha; Chris Black; Andrew T Watt; Eric G Marcusson; Susan M Freier; Thomas S Edgington
Journal:  FEBS Lett       Date:  2011-01-23       Impact factor: 4.124

2.  Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.

Authors:  Dorian R A Swarts; Sandra M H Claessen; Yvonne M H Jonkers; Robert-Jan van Suylen; Anne-Marie C Dingemans; Wouter W de Herder; Ronald R de Krijger; Egbert F Smit; Frederik B J M Thunnissen; Cornelis A Seldenrijk; Aryan Vink; Aurel Perren; Frans C S Ramaekers; Ernst-Jan M Speel
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

3.  TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.

Authors:  Sounak Gupta; Pedram Argani; Achim A Jungbluth; Ying-Bei Chen; Satish K Tickoo; Samson W Fine; Anuradha Gopalan; Hikmat A Al-Ahmadie; Sahussapont J Sirintrapun; Alejandro Sanchez; Abraham Ari Hakimi; Tiffany Mcfarlane; Paulo A Salazar; Sean R Williamson; Stephanie L Skala; Rohit Mehra; Ondrej Hes; Cristina R Antonescu; Marc Ladanyi; Maria E Arcila; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2019-11       Impact factor: 6.394

4.  Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.

Authors:  Ian J Davis; Bae-Li Hsi; Jason D Arroyo; Sara O Vargas; Y Albert Yeh; Gabriela Motyckova; Patricia Valencia; Antonio R Perez-Atayde; Pedram Argani; Marc Ladanyi; Jonathan A Fletcher; David E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

Review 5.  An emerging understanding of long noncoding RNAs in kidney cancer.

Authors:  Shuigen Zhou; Jiandong Wang; Zhengyu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-11       Impact factor: 4.553

6.  A distinctive translocation carcinoma of the kidney ["rosette-like forming," t(6;11), HMB45-positive renal tumor].

Authors:  Milan Hora; Ondrej Hes; Tomás Urge; Viktor Eret; Jirí Klecka; Michal Michal
Journal:  Int Urol Nephrol       Date:  2008-11-08       Impact factor: 2.370

Review 7.  Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis.

Authors:  José A Martina; Heba I Diab; Huiqing Li; Rosa Puertollano
Journal:  Cell Mol Life Sci       Date:  2014-01-30       Impact factor: 9.261

8.  MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.

Authors:  Shih-Feng Cho; Yuli Christine Chang; Chao-Sung Chang; Sheng-Fung Lin; Yi-Chang Liu; Hui-Hua Hsiao; Jan-Gowth Chang; Ta-Chih Liu
Journal:  BMC Cancer       Date:  2014-11-04       Impact factor: 4.430

9.  Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis.

Authors:  Ping Shuai; Yu Zhou; Bo Gong; Zhilin Jiang; Chong Yang; Hongji Yang; Dingding Zhang; Shikai Zhu
Journal:  Springerplus       Date:  2016-10-06

Review 10.  Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications.

Authors:  Ming Li; Ying Wang; Liang Cheng; Wanting Niu; Guoan Zhao; Jithin K Raju; Jun Huo; Bin Wu; Bo Yin; Yongsheng Song; Renge Bu
Journal:  Oncotarget       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.